Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (51)
Sotirios Tetradis, Matthew R. Allen & Salvatore L. Ruggiero. (2023) Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview. JBMR Plus.
Crossref
Crossref
Mario Dioguardi, Francesca Spirito, Mario Alovisi, Riccardo Aiuto, Daniele Garcovich, Vito Crincoli, Andrea Ballini, Giorgia Caloro & Lorenzo Lo Muzio. (2023) Location and Gender Differences in Osteonecrosis of the Jaws in Patients Treated with Antiresorptive and Antineoplastic Drugs Undergoing Dentoalveolar Surgical, Systematic Review with Meta-Analysis and Trial Sequential Analysis. Journal of Clinical Medicine 12:9, pages 3299.
Crossref
Crossref
Ilaria Roato, Rodolfo Mauceri, Vincenzo Notaro, Tullio Genova, Vittorio Fusco & Federico Mussano. (2023) Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw. International Journal of Molecular Sciences 24:9, pages 7948.
Crossref
Crossref
Rodolfo Mauceri, Martina Coppini, Massimo Attanasio, Alberto Bedogni, Giordana Bettini, Vittorio Fusco, Amerigo Giudice, Filippo Graziani, Antonia Marcianò, Marco Nisi, Gaetano Isola, Rosalia Maria Leonardi, Giacomo Oteri, Corrado Toro & Giuseppina Campisi. (2023) MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series. BMC Oral Health 23:1.
Crossref
Crossref
Ruyu Wang, Haoran Wang, Junyu Mu, Hua Yuan, Yongchu Pang, Yuli Wang, Yifei Du & Feng Han. (2023) Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases. The Journal of Biomedical Research 37:0, pages 1.
Crossref
Crossref
Dimitra Galiti, Aikaterini Karayianni, Kostas Tsiklakis & Amanda Psyrri. (2022) Medication Related Osteonecrosis of the Jaw (MRONJ). Review and recent advances. Forum of Clinical Oncology 13:1, pages 38-47.
Crossref
Crossref
Alessandro Cuozzo, Vincenzo Iorio-Siciliano, Emanuele Vaia, Leopoldo Mauriello, Andrea Blasi & Luca Ramaglia. (2022) Incidence and risk factors associated to Medication-Related Osteo Necrosis of the Jaw (MRONJ) in patients with osteoporosis after tooth extractions. A 12-months observational cohort study. Journal of Stomatology, Oral and Maxillofacial Surgery 123:6, pages 616-621.
Crossref
Crossref
Mehdi Ranjbar Pazouki, Arash Golestaneh & Atousa Aminzadeh. (2022) Effectiveness of local application of simvastatin for prevention of bisphosphonate-related osteonecrosis of the jaw: An animal study on rats. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 34:6, pages 713-718.
Crossref
Crossref
Saad Hajeri & Yasir Alturkistany. (2022) Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center. The Saudi Dental Journal 34:6, pages 479-484.
Crossref
Crossref
Rodolfo Mauceri, Rita Coniglio, Antonia Abbinante, Paola Carcieri, Domenico Tomassi, Vera Panzarella, Olga Di Fede, Francesco Bertoldo, Vittorio Fusco, Alberto Bedogni & Giuseppina Campisi. (2022) The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Supportive Care in Cancer 30:8, pages 6429-6440.
Crossref
Crossref
Salvatore L. Ruggiero, Thomas B. Dodson, Tara Aghaloo, Eric R. Carlson, Brent B. Ward & Deepak Kademani. (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery 80:5, pages 920-943.
Crossref
Crossref
Raed AlRowis, Abdulmalik Aldawood, Mohammed AlOtaibi, Essam Alnasser, Ibrahim AlSaif, Abdullah Aljaber & Zuhair Natto. (2022) Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies. The Saudi Dental Journal 34:3, pages 202-210.
Crossref
Crossref
Huanzhi Ma, Wei Zhang & Jun Shi. (2022) Differentially Expressed Genes Reveal the Biomarkers and Molecular Mechanism of Osteonecrosis. Journal of Healthcare Engineering 2022, pages 1-8.
Crossref
Crossref
M.M. Garunov, L.A. Grigoriyants, A.G. Stepanov, S.V. Apresyan & D.V. Simonyan. (2022) Clinical efficacy of hydroxyapatite and tricalcium phosphate modified with hyaluronic acid in the treatment of patients with periimplantitis. Stomatologiya 101:2, pages 42.
Crossref
Crossref
Donald B. Kimmel. 2022. Osteoporotic Fracture and Systemic Skeletal Disorders. Osteoporotic Fracture and Systemic Skeletal Disorders
317
338
.
Federica Bellone, Antonino Catalano, Angelo Ruggero Sottile, Agostino Gaudio, Saverio Loddo, Francesco Corica & Nunziata Morabito. (2021) Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D. Frontiers in Medicine 8.
Crossref
Crossref
Rodolfo Mauceri, Corrado Toro, Vera Panzarella, Martina Iurato Carbone, Vito Rodolico & Giuseppina Campisi. (2021) Oral Squamous Cell Carcinoma Mimicking Medication-Related Osteonecrosis of the Jaws (MRONJ): A Case Series. Oral 1:4, pages 326-331.
Crossref
Crossref
Antonia Marcianò, Ylenia Ingrasciotta, Valentina Isgrò, Luca L’Abbate, Saveria Serena Foti, Antonio Picone, Matteo Peditto, Gian Marco Guzzo, Angela Alibrandi & Giacomo Oteri. (2021) Cancer Patients at Risk for Medication-Related Osteonecrosis of the Jaw. A Case and Control Study Analyzing Predictors of MRONJ Onset. Journal of Clinical Medicine 10:20, pages 4762.
Crossref
Crossref
Vittorio Fusco, Manuela Alessio, Pamela Francesca Guglielmini, Maura Vincenti, Antonella Fasciolo & Maura Rossi. (2021) Is Medication-Related Osteonecrosis of the Jaws (MRONJ) Associated to Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors? A Word of Cautiousness. Comment on Marcianò et al. Medication-Related Osteonecrosis of the Jaws and CDK4/6 Inhibitors: A Recent Association. Int. J. Environ. Res. Public Health 2020, 17, 9509. International Journal of Environmental Research and Public Health 18:19, pages 10143.
Crossref
Crossref
Leanne Teoh, Geraldine Moses, Amanda P. Nguyen & Michael J. McCullough. (2020) Medication‐related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications. British Journal of Clinical Pharmacology 87:7, pages 2767-2776.
Crossref
Crossref
Sven Otto, Suad Aljohani, Riham Fliefel, Sara Ecke, Oliver Ristow, Egon Burian, Matthias Troeltzsch, Christoph Pautke & Michael Ehrenfeld. (2021) Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Medicina 57:5, pages 463.
Crossref
Crossref
Shaiba Sandhu & Vidya Sankar. (2021) Osteonecrosis of the jaw secondary to haematopoietic stem cell transplantation. BMJ Case Reports 14:3, pages e241298.
Crossref
Crossref
Yaron Haviv, Zehava Geller, Sigal Mazor, Yair Sharav, Naama Keshet & Yehuda Zadik. (2020) Pain characteristics in medication-related osteonecrosis of the jaws. Supportive Care in Cancer 29:2, pages 1073-1080.
Crossref
Crossref
Massimo De Martinis, Maria Maddalena Sirufo & Lia Ginaldi. (2020) Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints. Current Medicinal Chemistry 27:37, pages 6356-6372.
Crossref
Crossref
Yuqiong Zhou, Yejia Yu, Yueqi Shi, Mengyu Li, Chi Yang & Shaoyi Wang. (2020) Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study. BioMed Research International 2020, pages 1-9.
Crossref
Crossref
Giuseppina Campisi, Rodolfo Mauceri, Francesco Bertoldo, Giordana Bettini, Matteo Biasotto, Giuseppe Colella, Ugo Consolo, Olga Di Fede, Gianfranco Favia, Vittorio Fusco, Mario Gabriele, Antonio Lo Casto, Lorenzo Lo Muzio, Antonia Marcianò, Marco Mascitti, Marco Meleti, Michele D. Mignogna, Giacomo Oteri, Vera Panzarella, Umberto Romeo, Andrea Santarelli, Paolo Vescovi, Claudio Marchetti & Alberto Bedogni. (2020) Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. International Journal of Environmental Research and Public Health 17:16, pages 5998.
Crossref
Crossref
Aloizio Premoli Maciel, Reyna Aguilar Quispe, Lázara Joyce Oliveira Martins, Rogério Jardim Caldas & Paulo Sérgio da Silva Santos. (2020) Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review. Sao Paulo Medical Journal.
Crossref
Crossref
Rodolfo Mauceri, Vera Panzarella, Giuseppe Pizzo, Giacomo Oteri, Gabriele Cervino, Giuseppina Mazzola, Olga Di Fede & Giuseppina Campisi. (2020) Platelet-Rich Plasma (PRP) in Dental Extraction of Patients at Risk of Bisphosphonate-Related Osteonecrosis of the Jaws: A Two-Year Longitudinal Study. Applied Sciences 10:13, pages 4487.
Crossref
Crossref
Abdulrhman Al Abdullateef & Muhanad S. Alhareky. (2020) Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy. Saudi Pharmaceutical Journal 28:6, pages 771-778.
Crossref
Crossref
R. Mauceri, V. Panzarella, I. Morreale & G. Campisi. (2019) Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib. International Journal of Oral and Maxillofacial Surgery 48:12, pages 1530-1532.
Crossref
Crossref
S. Akkach, L. Shukla & D. Morgan. (2019) Everolimus-induced osteonecrosis of the jaw in the absence of bisphosphonates: a case report. British Journal of Oral and Maxillofacial Surgery 57:7, pages 688-690.
Crossref
Crossref
Vittorio Moraschini, Daniel Costa Ferreira de Almeida, Carlos Marcelo Figueredo & Monica Diuana Calasans-Maia. (2019) Association between biomarkers and medication-related osteonecrosis of the jaws: a systematic review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 127:6, pages 504-515.
Crossref
Crossref
Jonathan G. Messer, Jessica M. Jiron, Jorge L. Mendieta Calle, Evelyn J. Castillo, Ronnie Israel, Ean G. Phillips, Joshua F. Yarrow, Catherine Poznak, Lakshmyya Kesavalu, Donald B. Kimmel & J. Ignacio Aguirre. (2019) Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis. Oral Diseases 25:4, pages 1116-1135.
Crossref
Crossref
Rebecca King, Nikki Tanna & Vinod Patel. (2019) Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab—a review. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 127:4, pages 289-299.
Crossref
Crossref
Ourania Nicolatou-Galitis, Maria Kouri, Erofili Papadopoulou, Emmanouil Vardas, Dimitra Galiti, Joel B. Epstein, Sharon Elad, Giuseppina Campisi, Nikolaos Tsoukalas, Kivanc Bektas-Kayhan, Winston Tan, Jean-Jacques Body, Cesar Migliorati & Rajesh V. Lalla. (2018) Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Supportive Care in Cancer 27:2, pages 383-394.
Crossref
Crossref
Ruyu Wang, Haoran Wang, Junyu Mu, Hua Yuan, Yongchu Pang, Yuli Wang, Yifei Du & Feng Han. (2019) Molecular events in the jawvascular unit: A traditional review of the mechanisms involved in inflammatory jaw bone diseases. The Journal of Biomedical Research 0:0, pages 1.
Crossref
Crossref
Olga Di Fede, Vera Panzarella, Rodolfo Mauceri, Vittorio Fusco, Alberto Bedogni, Lorenzo Lo Muzio, SIPMO ONJ Board & Giuseppina Campisi. (2018) The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Giacomo Oteri, Giuseppina Campisi, Vera Panzarella, Ilaria Morreale, Riccardo Nucera, Olga Di Fede, Antonio Picone & Antonia Marcianò. (2018) Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?. BioMed Research International 2018, pages 1-6.
Crossref
Crossref
Elisabetta Merigo, Luigi Cella, Aldo Oppici, Maria Cristina Arbasi, Fabio Clini, Matteo Fontana & Carlo Fornaini. (2018) Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws. Journal of Lasers in Medical Sciences 9:2, pages 92-100.
Crossref
Crossref
J.G. Messer, J.L. Mendieta Calle, J.M. Jiron, E.J. Castillo, C. Van Poznak, N. Bhattacharyya, D.B. Kimmel & J.I. Aguirre. (2018) Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis. Bone 108, pages 79-88.
Crossref
Crossref
Hoda Abel Mahedi Mohamed, Charlotte Emilie Nor Nielsen & Morten Schiodt. (2018) Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 125:2, pages 157-163.
Crossref
Crossref
Kununya Pimolbutr, Stephen Porter & Stefano Fedele. (2018) Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature. BioMed Research International 2018, pages 1-14.
Crossref
Crossref
Giacomo Oteri, Gianluca Trifirò, Matteo Peditto, Loredana Lo Presti, Ilaria Marcianò, Francesco Giorgianni, Janet Sultana & Antonia Marcianò. (2017) Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient’s Quality of Life: A Single-Center, 10-Year Experience from Southern Italy. Drug Safety 41:1, pages 111-123.
Crossref
Crossref
Paul de Boissieu & Thierry Trenque. (2017) Denosumab treatment in postmenopausal women with osteoporosis. The Lancet Diabetes & Endocrinology 5:10, pages 767-768.
Crossref
Crossref
Eunae Sandra Cho, Seung Wook Jung, Hwi-Dong Jung, In Yong Lee, Tai-Soon Yong, Su Jin Jeong & Hyun Sil Kim. (2017) A Case of Pentastomiasis at the Left Maxilla Bone in a Patient with Thyroid Cancer. The Korean Journal of Parasitology 55:4, pages 433-437.
Crossref
Crossref
Giuseppina Campisi. (2017) Global Change and the Dentistry. A Wish from Italy and DoctOral App for the New Open Dental Journal “POJ Dental and Oral Care”. POJ Dental and Oral Care 1:1, pages 1-2.
Crossref
Crossref
Zdeněk Adam, Jan Straub, Marta Krejčí, Luděk Pour, Dagmar Brančíková, Lenka Ostřížková, Viera Sandecká & Martin Štork. (2017) Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks. Vnitřní lékařství 63:5, pages 311-321.
Crossref
Crossref
Emmanuelle Vigarios, Joel B. Epstein & Vincent Sibaud. (2017) Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Supportive Care in Cancer 25:5, pages 1713-1739.
Crossref
Crossref
Paul de Boissieu, L. Kanagaratnam, R. Mahmoudi, A. Morel, M. Dramé & T. Trenque. (2017) Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review. European Journal of Clinical Pharmacology 73:5, pages 517-523.
Crossref
Crossref
Gioacchino Catania, Federico Monaco, Giulia Limberti, Manuela Alessio, Iolanda De Martino, Cecilia Barile, Antonella Fasciolo, Anna Baraldi, Marco Ladetto & Vittorio Fusco. (2016) Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures. Dentistry Journal 4:4, pages 45.
Crossref
Crossref
Francesco Erovigni, Alessio Gambino, Marco Cabras, Antonella Fasciolo, Silvio Bianchi, Elisa Bellini & Vittorio Fusco. (2016) Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases. Dentistry Journal 4:4, pages 39.
Crossref
Crossref